Prestige Brands Extends Summer’s Eve Line On Ingredient Concerns
This article was originally published in The Rose Sheet
Executive Summary
Summer’s Eve helped drive the firm’s net sales up 3% to $257m in Prestige Brand’s latest quarter, but it also drove analysts’ questions on whether the brand will sustain growth despite health care advocates’ concerns about potential harmful effects from some ingredients common in feminine wipe products.
You may also be interested in...
Prestige Routes Summer’s Eve, Dentek ‘Brand Building’ On Dramamine Path
Prestige Consumer Healthcare is launching two products under Summer’s Eve brand for feminine hygiene during menstruation and professional-grade mouth guard under Dentek, as well as other products that will help grow "leading but under-invested” brands.
Feminine Cleanser Marketing Never Without Challenges; Now The Category Has FDA’s Attention
FDA is investigating use of certain ingredients in feminine cleansing and hygiene products, according to its fiscal 2019 budget justification. The agency’s work could draw unfavorable attention to a category that already comes under fire regularly for alleged body shaming and disproportionate ill effects on women of color, among other accusations.
OTC Evolution For Prestige Brands Combines Near- And Long-Term Strategies
BC, Goody's, Monistat marketer boosts domestic and international OTC revenues immediately with C.B. Fleet acquisition, looks ahead to manufacturing expansion.